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Summary
 
Major histocompatibility complex (MHC) class Ib molecules have been implicated in CD8
 
1
 
 T
cell–mediated defenses against intracellular bacterial infection, but the relative importance of
MHC class Ib–restricted T cells in antimicrobial immunity is unknown. In this report, we use
MHC tetramers to characterize T cell responses restricted by H2-M3, an MHC class Ib mole-
cule that selectively presents 
 
N
 
-formyl peptides. We find that sizeable H2-M3–restricted T cell
responses, occurring earlier than MHC class Ia–restricted T cell responses, are mounted after pri-
mary infection with the intracellular bacterium 
 
Listeria monocytogenes
 
. These H2-M3–restricted T
cells are cytolytic and produce interferon 
 
g
 
. However, after a second 
 
L
 
.
 
 monocytogenes
 
 infection,
H2-M3–restricted memory T cell responses are minor in comparison to the much larger MHC
class Ia–restricted responses. This first direct characterization of an MHC class Ib–restricted T
cell response indicates that CD8
 
1
 
 T cells responding to 
 
L
 
.
 
 monocytogenes
 
 infection can be divided
into two groups: H2-M3–restricted responses, which provide rapid and quantitatively substan-
tial effector function during primary infections but contribute relatively little to memory re-
sponses, and MHC class Ia–restricted responses, which expand later during primary infection
but form memory T cells that respond rapidly and dramatically in response to subsequent infec-
tions by the same pathogen.
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T
 
he mammalian immune system, molded by perpetual
battle with diverse and evolving pathogens, can be di-
vided into rapid, innate responses and somewhat delayed
adaptive responses. Innate immunity targets microbial prod-
ucts that have been conserved through evolution and are
shared by many microorganisms (1). The innate immune
system uses germline-encoded molecules to quickly respond
to a wide variety of pathogens. Many mechanisms have
evolved to specifically identify bacterial products: LPS, a
product of all gram-negative bacteria, is recognized by several
molecules of the immune system, including LPS binding
protein (2), CD14 (3), and CD11c/CD18 (4); macrophage
scavenger receptors detect components of both gram-posi-
tive and gram-negative bacterial cell walls as well as the in-
tact pathogens (5, 6); and the 
 
N
 
-formyl peptide receptor,
found on neutrophils and macrophages, binds peptides start-
ing with 
 
N
 
-formyl methionine, the amino acid that initiates
prokaryotic protein synthesis (7). These and perhaps many
other molecules provide early detection of invading bacteria,
thereby initiating antimicrobial defense and providing im-
portant cues for the developing adaptive immune response.
The adaptive, or specific immune system targets antigens
expressed by a vast array of pathogens by generating B and
T cell clones that each bear a rearranged specific antigen
receptor (8). CD8
 
1
 
 T cells constitute an important arm
of the adaptive immune response, recognizing pathogen-
derived peptides that are presented by MHC class I mole-
cules (9). MHC class I molecules have generally been di-
vided into two groups: members of the highly polymorphic
class Ia family present many different peptides to CD8
 
1
 
 T
cells and have well-defined roles in immune defense against
infection, whereas the function of molecules belonging to
the more conserved MHC class Ib family has remained
somewhat less clear (10–12). However, two different non-
polymorphic class Ib molecules appear specially suited for
presentation of bacterial products. The divergent class Ib
molecule CD1 is found outside the MHC locus in both
humans and mice but is similar to MHC-encoded class I
molecules in its structure and association with 
 
b
 
2-micro-
globulin (
 
b
 
2m)
 
1
 
 (13, 14). Human CD1b presents mycobac-
 
1
 
Abbreviations used in this paper:
 
 
 
b
 
2m, 
 
b
 
2-microglobulin; COI, cyto-
chrome c oxidase subunit I; ELISPOT, enzyme-linked immunospot; IPTG,
 
isopropyl-
 
b
 
-
 
d
 
-thiogalactopyranoside; LLO, listeriolysin O. 
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terial glycolipids, such as 
 
Mycobacterium tuberculosis
 
–derived
mycolic acids (15) and 
 
Mycobacterium leprae
 
–derived lipoarabi-
nomannan (16), to unique subsets of T cells. Murine CD1d1
has a deep, hydrophobic binding groove (14); it is known to
bind hydrophobic peptides of varying lengths and appears
ideal to bind lipids and glycolipids as well.
The other murine class Ib molecule involved in antibac-
terial immunity, H2-M3, shows a strong preference for
binding 
 
N
 
-formyl peptides (12). 
 
N
 
-formyl methionine is the
initiating amino acid for bacterial protein synthesis, while
in mammals only mitochondria use this amino acid. Thus,
like CD1, H2-M3 seems ideally suited for the presentation
of bacterial antigen to T cells. Unlike CD1, H2-M3 is en-
coded within the MHC and is believed to present only
peptide antigen. Crystallographic study of H2-M3 revealed
that the molecule has a structure very similar to that of
MHC class Ia molecules, although the peptide groove is
more hydrophobic, and the A pocket, which holds the first
peptide residue in most class I molecules, is blocked (17).
Binding of NH
 
2
 
-terminal formyl methionine occurs in the
B pocket, and, as a consequence, peptides bound to H2-M3
are relatively short in comparison to the 8- to 10-mers that
associate with class Ia molecules.
Early studies of T cell responses to infection with the
gram-positive bacterium
 
 Listeria monocytogenes
 
 demonstrated
the prominent role of CD8
 
1
 
 T cells in adaptive immunity
to the pathogen (18), and multiple 
 
Listeria
 
-derived antigens
recognized by MHC class Ia–restricted CD8
 
1
 
 T cells have
been identified (19). Bacterial peptides are also presented in
the context of the MHC class Ib molecule, H2-M3 (20,
21), a finding which explained the interesting observation
that some CD8
 
1
 
 T cells recognize 
 
L
 
.
 
 monocytogenes
 
–infected
cells in the absence of classical MHC restriction (22). Three
 
N
 
-formylated peptides derived from 
 
L
 
.
 
 monocytogenes
 
 and
presented to CD8
 
1
 
 T cells by H2-M3 have been identified
(23–25). Despite the potential importance of H2-M3–
restricted CD8
 
1
 
 T cells in immunity to bacterial infection,
their contribution relative to MHC class Ia–restricted re-
sponses remains unclear.
In this study, we investigate the H2-M3–restricted T cell
response specific for one of the
 
 L. monocytogenes
 
–derived
 
N
 
-formyl peptides, f-MIGWIIA (23), and compare it to
the well-characterized H2-K
 
d
 
–restricted, listeriolysin O
(LLO)
 
91–99
 
 specific T cell response. We show that H2-M3–
restricted responses to 
 
L
 
.
 
 monocytogenes
 
 are kinetically dis-
tinct from class Ia–restricted responses; functional CD8
 
1
 
CTLs specific for f-MIGWIIA become apparent and reach
a climax earlier than LLO
 
91–99
 
 specific T cells. Memory re-
sponses of H2-M3–restricted T cells are also distinctive; while
LLO
 
91–99
 
 specific (class Ia–restricted) T cells undergo very
dramatic, rapid expansion upon reinfection with 
 
L. monocy-
togenes
 
, relatively few f-MIGWIIA–specific cells are detected
during the recall response. These findings demonstrate that
T cell responses restricted by H2-M3 are distinct from those
restricted by class Ia molecules and suggest that H2-M3–
restricted T cells may have a unique, early role in immune
responses against primary bacterial infection while playing a
relatively minor role in memory responses.
 
Materials and Methods
 
Mice, Bacteria, and Listeria Infection.
 
Female
 
 
 
CB6/F1, BALB/c,
C57BL/6, and C3H/HeJ mice were purchased from The Jackson
Laboratory. 
 
L. monocytogenes
 
 strain 10403s was obtained from
Daniel Portnoy (University of California Berkeley, Berkeley,
CA) and grown in brain–heart infusion broth. Mice 8–12 wk old
were infected by tail vein injection with 2 
 
3 
 
10
 
3
 
 
 
L
 
.
 
 monocytogenes
 
for primary infection. Recall infection with 10
 
5
 
 bacteria was per-
formed 7 wk after primary infection. Splenocytes were harvested
at different time points during the course of infection as described
previously (26).
 
Generation of H2-M3 Tetramers.
 
H2-M3 tetramers were gener-
ated following the approach described previously (26, 27). The
cDNA for mouse 
 
b
 
2m was provided by Pamela Bjorkman (Cali-
fornia Institute of Technology, Pasadena, CA) and amplified with
the following primers: 5
 
9
 
-GGCATATGATCCAGAAAACCCC-
TCAA-3
 
9
 
 and 5
 
9
 
-CCGGATCCTACATGTCTCGATCCCA-
GTA-3
 
9
 
. The full-length cDNA clone for H2-M3 was obtained
from Chyung-Ru Wang (University of Chicago, Chicago, IL) and
modified and amplified by PCR. The following primers were
used: 5
 
9
 
-GGCATATGGGTTCACATTCATTACGTTATTT-
CCACACTGCG-3
 
9
 
 and 5
 
9
 
-CCGGATCCTAATCGCGCA-
GCTCCATCTTCATAGCCTCGAAGATACCACCCAGAC-
CACCACCCCATTTCAGGGCAAGGGG-3
 
9
 
. The former,
NH
 
2
 
-terminal primer, removed the leader sequence. The latter,
COOH-terminal primer, replaced the transmembrane and cyto-
plasmic domains with a biotinylation sequence. The initial H2-M3
sequence was modified to replace four C or G nucleotides at the
NH
 
2
 
 terminus with A or T, after the construct failed to produce
significant protein in 
 
Escherichia coli
 
 (see Fig. 1 A). This approach,
used to increase expression of eukaryotic proteins in bacteria, was
described previously by Garboczi et al. (28). Four nucleotides
were changed as follows (changes underlined): ATG GGC TCA
CAT TCA CTG CGC to ATG GGT TCA CAT TCA TTA
CGT. The changes did not alter the amino acid sequence. PCR
products were cloned into the pET3a isopropyl-
 
b
 
-
 
d
 
-thiogalacto-
pyranoside (IPTG)-inducible vector (Novagen, Inc.) and expressed
as recombinant proteins in the 
 
E
 
.
 
 coli
 
 expression host BL21(DE3).
H2-M3 heavy chain and 
 
b
 
2m were purified from inclusion bod-
ies as described previously (26), dissolved in 8 M urea, and re-
folded in the presence (or absence) of 
 
z
 
60 
 
m
 
g/ml f-MIGWIIA
or f-MFINRW (cytochrome c oxidase subunit I [COI]) peptide
(Research Genetics Inc.) and the protease inhibitors pepstatin
(1 
 
m
 
g/ml), leupeptin (1 
 
m
 
g/ml), and PMSF (0.4 mM). Soluble mo-
nomeric H2-M3/
 
b
 
2m/peptide complexes were purified by gel
filtration over a Superdex 200HR column (Amersham Pharmacia
Biotech). Purified monomeric complexes were biotinylated in vitro
at 20
 
8
 
C for 12 h in the presence of 15 
 
m
 
g BirA enzyme (Avidity),
80 
 
m
 
M biotin, 10 mM ATP, 10 mM MgOAc, 20 mM bicine, and
10 mM Tris-HCl (pH 8.3). Complexes were purified again by gel
filtration to remove excess biotin and tetramerized with PE-con-
jugated streptavidin (Molecular Probes, Inc.) at a 4:1 molar ratio.
Finally, tetramers were purified by gel filtration and stored at a
concentration of 
 
z
 
5 mg/ml at 4
 
8
 
C in PBS (pH 8.0) with 0.02%
sodium azide, 1 
 
m
 
g/ml pepstatin, 1 
 
m
 
g/ml leupeptin, and 0.5 mM
EDTA. H2-K
 
d
 
/LLO
 
91–99
 
 tetrameric complexes were produced as
described previously (26, 27).
 
In Vitro Restimulation of Splenocytes.
 
Splenocytes were har-
vested from BALB/c or C57BL/6 mice 7 d after infection. After
lysis of erythrocytes, 3–4 
 
3
 
 10
 
7
 
 splenocytes were resuspended in
5 ml RP10
 
1
 
 (RP 1640 [GIBCO BRL] supplemented with 10%
FCS, 
 
l
 
-glutamine [0.2 
 
m
 
g/ml], Hepes [1.2 
 
m
 
g/ml, pH 7.5],
 
b
 
-ME [50 
 
m
 
m], penicillin [100 U/ml], streptomycin [100 
 
m
 
g/ 
197
 
Kerksiek et al.
 
ml], and gentamicin [50 
 
m
 
g/ml]). Stimulator cells were prepared
from syngeneic naive mice. Splenocytes were irradiated (3,000
rads) and then pulsed with 10
 
2
 
6
 
 M f-MIGWIIA or LLO
 
91–99
 
peptide for 1 h at 37
 
8
 
C. Cells were washed to remove unbound
peptide, and 3 
 
3
 
 10
 
7
 
 cells resuspended in 5 ml RP10
 
1
 
 were
added to 5 ml immune splenocytes in a T 25 cell culture flask.
Cultures were stimulated every week with 3 
 
3
 
 10
 
7
 
 peptide-
coated splenocytes to generate T cell lines. RP10
 
1
 
 medium was
supplemented with 5% T-STIM Culture Supplement (Collabo-
rative Biomedical Products) after the second restimulation. Three
BALB/c T cell clones were generated from a f-MIGWIIA–
specific CTL line after 3 wk of restimulation in vitro. Limiting
dilution was performed in a 96-well plate, and medium was re-
placed weekly until expansion was sufficient to allow restimula-
tion in a T 25 culture flask.
 
Enrichment, Staining, and Analysis of CD8
 
1
 
 T Cells.
 
Splenocytes
were enriched for CD8
 
1
 
 T cells by depletion using magnetically
activated cell sorting (MACS
 
®
 
; Miltenyi Biotec). Cells were first
incubated with antibodies against CD4 (GK1.5), MHC class II
(TIB120), and MAC-1 (TIB128) for 20 min on ice in separation
buffer (PBS, 0.5% BSA, and 2 mM EDTA, pH 7.45). After
extensive washing, spleen cells were incubated with goat anti–rat
IgG magnetic microbeads (Miltenyi Biotec) for 20 min at 4
 
8
 
C.
Splenocytes were washed again, applied to a type LS column
(Miltenyi Biotec), and separated using the MidiMACS® (Mil-
tenyi Biotec) following the manufacturer’s instructions. For stain-
ing, z3 3 105 CD81-enriched splenocytes were blocked with
unconjugated streptavidin (0.5 mg/ml; Molecular Probes, Inc.)
and Fc-block (PharMingen) in staining buffer (SB; PBS, 0.5%
BSA, 0.02% sodium azide, pH 7.45) in a 96-well plate for 20 min
on ice. Cells were then triple stained with anti-CD62L–FITC (clone
MEL-14; PharMingen); PE-conjugated H2-M3/f-MIGWIIA,
H2-M3/COI, or H2-Kd/LLO91–99 tetrameric complexes (0.25–
0.5 mg/ml); and anti-CD8a–CyChr (clone 53-6.7; PharMingen)
in SB for 1 h on ice. After three washes in SB, cells were fixed in
1% paraformaldehyde/PBS (pH 7.45). Data were acquired using a
FACSCalibur™ flow cytometer and analyzed using CELLQuest
software (Becton Dickinson). For cell sorting, staining of enriched
CD81 T cells from each spleen was performed in a single tube
using a staining buffer of PBS supplemented with 0.5% FCS, and
cells were not fixed before sorting.
Chromium-release Assays. P815 target cells (American Type
Culture Collection) were labeled with 51Cr and washed. FACS®-
sorted cells were incubated with 5 3 103 labeled cells alone or in
the presence of 1026 M f-MIGWIIA, f-MFINRW (COI self), or
LLO91–99 peptide for 7.5 h at 378C. The percent specific lysis was
calculated as described previously (26) based on the amount of
51Cr release.
Enzyme-linked Immunospot Assay. The enzyme-linked immu-
nospot (ELISPOT) assay for detecting IFN-g–producing T cells
was performed as described previously (29). In brief, P815 target
cells were irradiated (10,000 rads) and coated with 1026 M
f-MIGWIIA or LLO91–99 peptide, or incubated in the absence of
peptide, for 1 h at 378C. After washing, 105 target cells were
added along with 105 immune splenocytes to each well of a 96-
well nitrocellulose plate (Millipore, Inc.) coated with anti–IFN-g
antibody (clone R4-6A2; PharMingen). The plate was incubated
for 24 h at 378C in the presence of 30 U/ml IL-2. IFN-g pro-
duction was detected with biotin-labeled anti–IFN-g antibody
(clone XMG1.2; PharMingen), followed by addition of streptavi-
din peroxidase (Kirkegaard & Perry Labs., Inc.) and development
with a substrate solution of 1 mg/ml DAB (HRP Color Devel-
opment Reagent; Bio-Rad Laboratories), 50 mM Tris-HCl, and
0.5 ml/ml 30% hydrogen peroxide. Spots were counted under a
dissecting microscope.
Results
Generation of H2-M3 Tetramers. H2-M3 is an MHC
class Ib molecule that binds N-formylated, hydrophobic
peptides and presents antigen derived from intracellular bac-
teria to CD81 T cells (12). To visualize H2-M3–restricted
T cell responses to bacterial infection, we generated tetra-
meric complexes of H2-M3 with the L. monocytogenes–
derived peptide, f-MIGWIIA (23). As a negative control,
H2-M3 tetramers complexed with a mitochondrially derived
self-peptide, COI (f-MFINRW [30]), were generated. We
PCR mutagenized H2-M3 to remove the leader, trans-
membrane, and cytosolic regions and to add a COOH-ter-
minal biotinylation site (31, 32), but expression of this con-
struct in E. coli was poor (Fig. 1 A). We then modified the
59 end of the coding sequence, changing four C/G into A/T
nucleotides within the first seven codons without altering
the amino acid sequence of the protein (see Materials and
Methods, and reference 28). These changes greatly enhanced
IPTG-inducible expression of recombinant H2-M3 in E. coli
(Fig. 1 B), thereby allowing purification of high quantities
of recombinant protein for in vitro refolding. Purified
H2-M3 and b2m were solubilized in 8 M urea and refolded
in the presence of synthetic f-MIGWIIA or COI peptide.
To ensure that refolding and stabilization of soluble H2-M3
complexes were peptide dependent, refolding reactions were
performed in the absence of peptide (Fig. 1 E) or in the
presence of f-MIGWIIA (Fig. 1 C) or COI (Fig. 1 D) pep-
tide. Size-exclusion chromatography demonstrated that heavy
chain and b2m form stable complexes in the presence (Fig. 1,
C and D) but not the absence (Fig. 1 E) of N-formylated
peptide. Purified H2-M3 complexes were biotinylated and
tetramerized with PE-conjugated streptavidin. Tetrameric
complexes were further purified by gel filtration before
concentration and used as staining reagents for flow cyto-
metric analyses (27).
Staining and Specificity of H2-M3 Tetramers. Tetrameric
complexes refolded with the L. monocytogenes–derived
f-MIGWIIA peptide were tested for specific staining of in
vitro peptide-restimulated CTL lines and clones generated
from L. monocytogenes–infected mice. All CTL lines and
clones specifically killed target cells coated with the stimu-
lating peptide when tested in chromium-release assays (data
not shown). f-MIGWIIA–specific CTL lines derived from
both C57BL/6 and BALB/c mouse strains demonstrated
high intensity staining with H2-M3/f-MIGWIIA tetramers
(Fig. 2, A and B). Within some CTL lines, particularly those
stimulated in vitro for a short time, a fraction of cells
stained with low intensity or did not stain with the tetra-
mers (Fig. 2 B, and data not shown). However, all three
f-MIGWIIA–specific CTL clones stained with uniformly
high intensity with H2-M3/f-MIGWIIA tetramers (Fig. 2 C,
and data not shown). These data indicate that although
H2-M3/f-MIGWIIA tetramers stain most f-MIGWIIA–198 H2-M3–restricted T Cell Responses to Bacterial Infection
specific CTLs, a small portion of T cells, perhaps those with
lower affinity for the MHC/peptide complex, may not be
detected. H2-M3/f-MIGWIIA tetramers did not stain CTLs
specific for the H2-Kd–restricted peptide LLO91–99 (Fig. 2 D),
demonstrating their specificity in staining, similar to the
findings for H2-Kd/LLO91–99 tetramers (26; Fig. 2, A–C).
Some CTL lines specific for the other Listeria-derived,
N-formylated peptides stained, to varying but generally small
degrees, with H2-M3/f-MIGWIIA tetramers (data not
shown). This staining correlated with cross-reactive killing in
CTL assays and is not entirely surprising, given the cross-
reactivity in recognition of N-formylated peptides demon-
strated by Nataraj et al. (33). No staining of cell lines was
detected with H2-M3 tetramers refolded with the COI self-
peptide (data not shown). These studies show that H2-M3/
f-MIGWIIA tetramers can be used to stain f-MIGWIIA–
specific T cell populations and demonstrate that the staining
is specific.
Comparison of H2-M3–restricted T Cell Populations in Dif-
ferent Mouse Strains. Most common laboratory mouse strains
share the same allele of H2-M3 (12). To determine whether
this translates into similar H2-M3–restricted T cell responses
to bacterial infection, H2-M3/f-MIGWIIA and H2-M3/
COI tetramers were used to stain splenocytes from L. mono-
cytogenes–infected mice. Interestingly, direct ex vivo staining
for H2-M3–restricted T cells revealed relatively high num-
bers of activated (CD62Llow) f-MIGWIIA–specific T cells
compared with previously reported findings for the immu-
nodominant LLO91–99 specific response (26), although the
magnitude of H2-M3–restricted responses differed among
mouse strains. Throughout the peak phase of the primary
response (days 5–9 after infection), C57BL/6 and C3H/HeJ
Figure 1. Expression and peptide-depen-
dent refolding of recombinant H2-M3. (A)
H2-M3 cDNA was modified by PCR (as
described in Materials and Methods), cloned
into the pET3a vector, and expressed in
E. coli strain BL21(DE3). Samples taken be-
fore and 1 and 3 h after IPTG induction
were subjected to SDS-PAGE, followed by
staining with Coomassie blue. The number
of hours of IPTG induction before collec-
tion of each sample is indicated above the
gel. (B) The H2-M3 construct containing
the biotinylation sequence was further mu-
tagenized by PCR to replace four C/G nu-
cleotides in the first seven codons of the 59
coding region with A/T nucleotides (see
Materials and Methods). These changes
greatly increased H2-M3 expression in E. coli
after IPTG induction. Samples taken before
and after IPTG induction were treated as in
A. H2-M3 and b2m protein were refolded
in the presence of the Listeria-derived
f-MIGWIIA peptide (C) or the mitochon-
drial COI self-peptide (D) as described in
Materials and Methods, concentrated, and
subjected to size-exclusion chromatography
on a Superdex 200HR column. Absorbance
at 280 nm was measured and plotted. (E)
Refolding of H2-M3/b2m complexes was
also attempted in the absence of exogenous
formyl peptide.
Figure 2. H2-M3/f-MIGWIIA tetramers stain CTL lines and clones specific for the f-MIGWIIA peptide. f-MIGWIIA– and LLO91–99 specific CTL
lines and clones were generated by in vitro peptide restimulation of splenocytes from L. monocytogenes–infected mice as described in Materials and Meth-
ods. Cells were stained with anti-CD8, anti-CD62L, PE-conjugated H2-M3/f-MIGWIIA or H2-Kd/LLO91–99 tetramers, and propidium iodide to iden-
tify dead cells. Histograms show tetramer staining gated on live CD81 CTLs from f-MIGWIIA–specific C57BL/6 (A) and BALB/c (B) derived CTL
lines, a BALB/c f-MIGWIIA–specific CTL clone (C), and a BALB/c LLO91–99 specific CTL line (D).199 Kerksiek et al.
mice had significantly higher numbers of H2-M3/f-MIG-
WIIA tetramer–staining T cells than BALB/c mice (Fig. 3).
In this set of experiments, the differences were most evi-
dent 7 d after infection, when C57BL/6 and C3H/HeJ mice
had large, distinct populations of activated T cells staining
with H2-M3/f-MIGWIIA tetramers (Fig. 3 A). At the
same time point, BALB/c mice had smaller populations of
f-MIGWIIA–specific cells that stained with lower intensity
(Fig. 3 A). A diffuse staining of cells within the CD81CD62Lhi
(unactivated) population with H2-M3/f-MIGWIIA tetramers
was also detected, although at very similar levels among the
mouse strains investigated (Fig. 3 A, and data not shown).
A comparable degree of staining of CD81CD62Lhi cells
was also found with H2-Kd tetramers (26; Figs. 4 and 5).
Further experiments will be needed to determine the origin
and specificity of this “background” staining. Nevertheless,
this experiment demonstrates that L. monocytogenes–infected
mice of different strains generate H2-M3–restricted T cell
Figure 3. The magnitude of f-MIGWIIA–specific CTL responses to
L. monocytogenes infection is different among mouse strains. Female age-
matched C57BL/6, C3H/HeJ, and BALB/c mice were infected with
2,000 L. monocytogenes, and splenocytes were obtained on the indicated
day after primary infection, enriched for CD81 T cells, and stained with
antibodies to CD8 and CD62L as well as one of the PE-conjugated tet-
ramers. Two mice per strain were analyzed each day. (A) The dot plots
show H2-M3/f-MIGWIIA (left panels) and H2-M3/COI self (right pan-
els) tetramer stainings for one mouse per strain on day 7 after infection.
Staining for CD62L (l-selectin) is shown on the x-axis, and tetramer
staining on the y-axis. Dot plots are gated on CD81 lymphocytes. Per-
centages in the upper left quadrants represent the percentage of CD81
CD62Llow (activated) cells that are tetramer positive. (B) The average
number of H2-M3/f-MIGWIIA and H2-M3/COI (self) tetramer–posi-
tive cells per spleen is shown for two mice of each strain on days 5, 7, and
9 after infection. SD are indicated.
Figure 4. H2-M3–restricted T cell responses peak earlier than H2-Kd–
restricted responses during primary L. monocytogenes infection. Female, age-
matched CB6/F1 mice were infected with 2,000 L. monocytogenes. Spleno-
cytes were taken from uninfected mice (day 0) and infected mice on the
indicated day after infection. CD81-enriched splenocytes were stained with
anti-CD8, anti-CD62L, and one of three PE-conjugated tetramers: H2-M3/
f-MIGWIIA, H2-M3/COI self, or H2-Kd/LLO91–99. Dot plots are gated
on CD81 lymphocytes, with CD62L staining on the x-axis and tetramer
staining on the y-axis. The percentage of CD62Llow (activated), tetramer-
staining cells is indicated in the upper left quadrant. Dot plots for each day
are from one representative mouse. Four log phases are shown.200 H2-M3–restricted T Cell Responses to Bacterial Infection
responses of different sizes that can be detected directly ex
vivo with H2-M3/f-MIGWIIA tetramers. In addition, de-
spite the large differences in magnitude, H2-M3–restricted,
f-MIGWIIA–specific T cell responses showed similar ki-
netics among the mouse strains (Fig. 3 B).
H2-M3–restricted T Cell Responses to Primary Infection with
L. monocytogenes. CD81 T cell populations specific for
different peptides bound to the MHC class Ia molecule
H2-Kd expand and contract in a coordinated fashion in re-
sponse to infection with L. monocytogenes, despite very dif-
ferent magnitudes of the T cell responses (26). To investi-
gate whether T cells restricted by H2-M3 follow the same
kinetics, we studied the expansion and contraction of
f-MIGWIIA–specific T cells in CB6/F1 mice (H2b3d).
This F1 hybrid of C57BL/6 and BALB/c strains generates
H2-M3–restricted, f-MIGWIIA–specific T cell responses of
intermediate size compared with the parental strains (Figs.
3 and 4) and also develops H2-Kd–restricted, LLO91–99 spe-
cific T cell responses. As described previously in BALB/c
mice (26), a distinct LLO91–99 specific T cell population was
first detectable on day 5 after infection with L. monocytog-
enes (Fig. 4 and Fig. 6 A). Further expansion resulted in a
peak of the LLO91–99 specific T cell response 7–9 d after in-
fection; the percentage of tetramer-staining T cells contin-
ued to increase until day 9, but the absolute number reached
a plateau due to a decreasing number of total splenocytes
after day 7 (Fig. 6 A). H2-M3–restricted T cells became
visible 3 d after primary infection and expanded dramati-
cally between days 3 and 5 after infection. Strikingly, these
f-MIGWIIA–specific T cells were already at or near their
peak magnitude at this early time point; the absolute num-
ber of specific T cells was highest between days 5 and 7
after infection (Fig. 6 A). No significant staining with
H2-M3 tetramers complexed with the COI self-peptide
was detected at any point. T cell responses to two other
H2-M3–restricted, Listeria-derived peptides, though smaller
than f-MIGWIIA–specific responses, followed the same ki-
netics as determined by tetramer staining (data not shown).
For each peptide-specific T cell population, the peak response
was followed by a contraction phase, and by 7 wk after in-
fection, the low numbers of remaining f-MIGWIIA– and
LLO91–99 specific T cells were near the limits of detection.
Although a certain degree of variability is inherent in T cell
responses to infection, the relative kinetics of H2-Kd– and
H2-M3–restricted T cell populations are highly reproduc-
ible, with the climax of H2-M3–restricted T cells preced-
ing that of H2-Kd–restricted T cells by z2 d in several
studies (Figs. 3 and 4, and data not shown). Indeed, in the
strain comparison reported here (Fig. 3), f-MIGWIIA–
specific cells from three strains synchronously peaked on
day 7 after infection (Fig. 3 B), whereas LLO91–99 specific
cells in H2d BALB/c mice reached their highest magnitude
around day 9 after infection (data not shown). These experi-
ments indicate that although magnitude and exact kinetics of
H2-M3–restricted responses vary somewhat among mice in-
vestigated, f-MIGWIIA–specific CD81 T cell populations
respond earlier than H2-Kd–restricted T cell populations
upon infection with L. monocytogenes.
Memory T Cell Responses upon Reinfection with L. monocytog-
enes. Exposure to pathogens can result in immunological
memory, which leads to faster and more effective immune
responses when the same pathogen is encountered at a later
time (34). We have previously shown that in BALB/c mice
reinfected with L. monocytogenes, H2-Kd–restricted, Listeria-
specific T cells respond more quickly and reach much higher
frequencies than seen during primary infection (26, 27, 35).
The rapid expansion of LLO91–99 specific T cells during re-
call infection is also seen in CB6/F1 mice; by day 3 after
reinfection, the percentage of LLO91–99 specific T cells was
Figure 5. H2-M3–restricted T cells undergo little expansion during re-
call L. monocytogenes infection compared with H2-Kd–restricted T cells.
Female, age-matched CB6/F1 mice were infected with 2,000 L. monocy-
togenes. After 48 d, the mice were reinfected with 100,000 bacteria. Day 0
represents a mouse not reinfected with L. monocytogenes, and is the same as
day 48 from Fig. 4. Splenocytes were taken on the indicated days and
were stained and analyzed as described in the legend to Fig. 4.201 Kerksiek et al.
as high as the peak primary response (Figs. 4 and 5). Between
days 3 and 5, there was a dramatic expansion of LLO91–99
specific T cells, and at the peak of the recall response, 5 d
after reinfection, the population of LLO91–99 specific T cells
constituted 10–20% of the entire CD81 T cell compart-
ment (Fig. 5 and Fig. 6 B, and data not shown). H2-M3–
restricted, f–MIGWIIA peptide–specific T cell responses
were remarkably different from LLO91–99 specific responses
in the same mouse. The two epitope-specific T cell popu-
lations started out at approximately the same frequency be-
fore reinfection (day 0), and numbers decreased slightly in the
spleen on day 1 after infection, as reported previously (26).
By the third day after reinfection, a population of H2-M3/
f-MIGWIIA tetramer–staining cells was clearly detected;
this contrasts with primary infection, during which no clear
population of H2-M3/f-MIGWIIA–staining cells was seen
3 d after infection. Although the peak of both primary and
recall H2-M3–restricted T cell responses occurred z5 d af-
ter infection, the magnitude of the f-MIGWIIA–specific T
cell population after reinfection was lower than the peak
primary response specific for the peptide and .10-fold
lower than the recall LLO91–99 specific T cell response in the
same mouse (Fig. 5 and Fig. 6B). Similar results were ob-
tained in the B10.D2 mouse strain (data not shown). These
experiments show that H2-M3– and H2-Kd–restricted T
cell populations differ greatly in their extent of expansion
after reinfection with L. monocytogenes. In addition, unlike
the primary response, during which f-MIGWIIA and the
LLO91–99 specific T cell responses have remarkably different
timing in expansion and contraction, after reinfection with
L. monocytogenes, the two populations have similar kinetics.
Functional Qualities of H2-M3–restricted T Cells. The pre-
vious experiments described in this report demonstrate that
Listeria-specific H2-M3–restricted T cells are detectable
and peak earlier than H2-Kd–restricted responses after pri-
mary infection, but they do not indicate whether this early
expansion might have implications for bacterial clearance.
To determine whether H2-M3–restricted L. monocytogenes–
specific T cells present 5 d after primary infection have
characteristics of functional CD81 T cells, we placed im-
mune splenocytes directly into a chromium-release assay to
assess cytolytic ability (Fig. 7 A) and an ELISPOT assay to de-
tect IFN-g production (Fig. 7 B). FACS®-sorted CD62Llow
(activated), f-MIGWIIA–specific CD81 T cells demonstrated
significant specific killing activity against f-MIGWIIA–coated
target cells (Fig. 7 A, left panel). Splenocytes depleted of
H2-M3/f-MIGWIIA tetramer–staining cells (Fig. 7 A, right
panel) had little activity against f-MIGWIIA peptide, indi-
cating that essentially all f-MIGWIIA–specific T cells were
detected with the tetramers. No LLO91–99 specific killing
activity was detected at this early time point after infection.
Splenocytes from another mouse were stained with H2-Kd/
LLO91–99 tetramers at the same time and subjected to an
identical sorting process for tetramer-positive and tetramer-
negative cells within the CD81CD62Llow population. Too
few H2-Kd/LLO91–99 tetramer–positive cells were detected
to sort effectively. However, within the tetramer-negative
population, significant f-MIGWIIA–specific killing was
found, with .15% specific lysis of target cells (data not
shown). H2-M3–restricted T cells also secreted IFN-g 5 d
after primary infection (Fig. 7 B). Approximately four
times more IFN-g–secreting f-MIGWIIA peptide–specific
cells than LLO91–99 specific cells were detected. These exper-
iments demonstrate that H2-M3–restricted T cells detected
early (day 5) after primary infection are functional CD81 T
cells, with both cytolytic and IFN-g–secreting abilities.
Discussion
In this report, we characterize H2-M3–restricted CD81
T cell responses after infection with the intracellular bacterium
L. monocytogenes. Our studies demonstrate that these MHC
class Ib–restricted T cell responses are distinctive, differing
in several ways from MHC class Ia–restricted responses. More
Figure 6. H2-M3–restricted
T cell responses differ from
H2-Kd–restricted T cells during
both primary infection and rein-
fection with L . monocytogenes.
The total number of CD81
CD62Llow (activated), tetramer-
positive cells (for H2-M3/
f-MIGWIIA, H2-M3/COI self,
and H2-Kd/LLO91–99 tetramers)
was quantified from mice at each
time point during primary and
recall studies. Absolute numbers
(y-axis) are shown for primary
infection (A) and recall infection
(B) with days after infection
marked on the x-axis. Averages
and SD are shown for three mice
per day except primary days 0
(uninfected), 20, and 48 (recall
day 0), at which times there
were two mice. Note that y-axes
have different scales for primary
and recall infections.202 H2-M3–restricted T Cell Responses to Bacterial Infection
specifically, we show that (a) functional H2-M3–restricted T
cell populations are detectable and achieve their maximal
size earlier than H2-Kd–restricted T cell populations after
primary infection; (b) H2-M3–restricted T cell responses
after recall bacterial infection do not exhibit the typical
memory features of faster expansion and greater magnitude;
and (c) mouse strains that share the same H2-M3 allele
generate H2-M3–restricted T cell responses with similar
kinetics but different magnitudes. Our results suggest that
CD81 T cells restricted by the class Ib molecule H2-M3
have an early and perhaps unique role in primary defense
against infection with intracellular bacteria but may play
only a minor role in memory responses.
Why do H2-M3–restricted T cells expand more rapidly
during a primary immune response to L. monocytogenes than
other T cells? One possibility is that N-formylated peptides
are presented earlier during infection than other epitopes,
giving H2-M3–restricted T cells a temporal advantage over
other T cells. The efficiency of L. monocytogenes N-formyl
peptide presentation by H2-M3 is not known. However,
bacterially secreted N-formyl peptides are likely to require
much less processing to be presented by class I molecules
than epitopes occupying internal positions in proteins. In
addition, it is known that H2-M3 is poorly represented on
the cell surface due to the paucity of mitochondrial self-
peptides (36). Therefore, it is possible that bacterial infec-
tion induces the surface expression of H2-M3 due to a sud-
den abundance of N-formylated peptides. In this setting,
bacterially derived N-formylated epitopes could be pre-
sented quickly, whereas presentation of bacterial peptides
bound by class Ia molecules might be delayed as they com-
pete for presentation with a plethora of self-peptides. Al-
though these mechanisms might provide H2-M3–restricted
T cells with a relative time advantage, it seems unlikely
that they could account for the 2-d lead over the H2-Kd–
restricted T cell responses.
An alternative explanation for the early response of
H2-M3–restricted T cells is that they may have been primed
in vivo before L. monocytogenes infection. Indeed, in its rel-
atively rapid expansion after L. monocytogenes infection, the
H2-M3–restricted T cell response more closely resembles a
memory response than a primary response to antigen. The
notion that commensal bacteria may prime H2-M3–restricted
T cells was proposed by Lenz and Bevan when they found
that mice housed in non-specific pathogen–free (SPF)
facilities had established immunity to the Listeria-derived
f-MIGWII and f-MIVIL peptides in the absence of previ-
ous infection with L. monocytogenes (37). We have also noted
that older mice often generate larger H2-M3–restricted T
cell responses than younger mice (Kerksiek, K., and E.G.
Pamer, unpublished results), suggesting that exposure to
environmental bacteria, such as the normal flora of the gut,
may modulate the repertoire of T cells specific for foreign
bacteria. This hypothesis requires the assumption that envi-
ronmental bacteria either express the same formyl peptides
expressed by L. monocytogenes and other foreign bacteria, or
that formyl peptides are promiscuously recognized by
H2-M3–restricted T cells, perhaps due to their relative short-
ness or hydrophobicity. Recent studies of f-MIGWII–speci-
fic T cell clones demonstrated a remarkable degree of peptide
cross-recognition, supporting the latter of these two possi-
bilities (33). Although T cells responding to f-MIGWIIA
display the characteristic memory phenotype of rapid in vivo
expansion, further experiments will have to be performed
to dissect the role of bacterial exposure in the generation of
H2-M3–restricted T cell responses.
Although a relatively rapid H2-M3–restricted T cell
response is generated during primary infection with L. mono-
Figure 7. H2-M3–restricted T
cells detected 5 d after primary in-
fection are effective killers and se-
crete IFN-g. (A) Splenocytes
from a CB6/F1 mouse infected
with 2,000 L. monocytogenes 5 d
previously were enriched for
CD81 T cells followed by stain-
ing with anti-CD8, anti-CD62L,
and PE-conjugated H2-M3/
f-MIGWIIA tetramers. Tetra-
mer-positive (left panel) and tet-
ramer-negative (right panel) cells
were sorted separately from the
CD81CD62Llow staining popula-
tion and placed in a CTL assay
with peptide-coated p815 target
cells. The peptide used and per-
cent specific lysis are shown on
the x-axis and y-axis, respectively.
The E/T ratios were z1:1 for the
tetramer-positive cells and 10:1
for the tetramer-negative popula-
tion. (B) Unsorted splenocytes
from both immunized mice were placed in an ELISPOT assay for detection of IFN-g–secreting cells. The number of IFN-g–secreting cells detected is
shown as the average of two mice (y-axis), with SD indicated. Four replicate wells were counted for each mouse. The stimulating peptide is indicated on the
x-axis.203 Kerksiek et al.
cytogenes, these cells do not expand dramatically upon reinfec-
tion with the bacterium. It is possible that H2-M3–restricted
memory T cells are not generated during the primary im-
mune response or are not maintained after the resolution of
infection. However, our tetramer stainings, while near the
limits of detection, suggest that f-MIGWIIA– and LLO91–99
specific T cells are present at comparable levels 7 wk after
primary infection. We favor the possibility that expansion
of H2-M3–restricted memory T cells requires a greater du-
ration of antigen exposure than required by LLO91–99 spe-
cific T cells, which undergo dramatic in vivo expansion after
reinfection. Bacterial infection during the recall response is
limited to 1 or 2 d (26; and data not shown), which might
be insufficient for f-MIGWIIA–specific T cell expansion.
Thus, while a “memory response” during primary infec-
tion and the lack of such during recall infection may appear
paradoxical, the vastly different kinetics of bacterial infection
in these two circumstances may provide an explanation.
Common laboratory mouse strains share the same H2-M3
allele and should therefore be capable of generating functional
H2-M3–restricted T cells in response to bacterial infection.
Indeed, all of the mouse strains investigated here show such a
response. However, the magnitudes of these responses dif-
fered quite dramatically; in particular, BALB/c mice gener-
ated significantly fewer H2-M3–restricted, L. monocytogenes–
specific T cells than did C57BL/6 and C3H/HeJ mice. There
are several reasons why these differences might occur. One
possibility is that thymic or peripheral selection of the T
cells occurs differently among these mouse strains; it is un-
clear how the repertoire of H2-M3–restricted T cells is se-
lected (12). If selection of H2-M3–restricted T cells occurs
on H2-M3/self-peptide complexes expressed in the thymus,
the different mouse strains should possess similar reper-
toires, as the same mitochondrial proteins are present in these
strains. However, if the repertoire of H2-M3–restricted cells
is influenced by resident bacterial flora such as those found
in the gut, then distinct subsets of H2-M3–restricted T cells
might be selected in different mouse strains. Another factor
that might account for the varied H2-M3–restricted T cell
responses in different mouse strains is the genetic back-
ground of the host. Indeed, mouse strains are known to vary
dramatically in susceptibility to L. monocytogenes infection (38),
and the basis for this remains largely unexplored. It is possi-
ble that complex genetic factors that influence infectious dis-
ease susceptibility can affect the magnitude of T cell responses.
Primary L. monocytogenes infection of immunocompetent
mice generally resolves within 6–7 d. Although CD81 T
cells are known to be important in the clearance of infec-
tion, maximal T cell responses restricted by H2-Kd occur after
the infection has been cured. However, H2-M3–restricted
CD81 T cells respond to primary L. monocytogenes infection
z2 d earlier than their MHC class Ia–restricted cousins, re-
sulting in significant numbers of cytolytic, IFN-g–produc-
ing H2-M3–restricted T cells on the fifth day after infection
(Fig. 7). This finding suggests that H2-M3–restricted T
cells play an important role in the early control of primary
infection with L. monocytogenes. Remarkably, although the
H2-M3–restricted T cell population appears very vigorous
during primary infection, MHC class Ia–restricted T cells
seem to be more important for providing T cell memory.
This is the first demonstration, to our knowledge, of tem-
poral diversity and differential memory capacity within
CD81 T cell populations responding to bacterial infection.
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